Drug intelligence / Profile preview

fludroxycortide

Development stage
Unknown
Lead developer
Typharm
Modality
Small Molecules
Administration
Topical
01

Overview

Fludroxycortide is a synthetic, moderately potent topical corticosteroid used for its anti-inflammatory, antipruritic, and vasoconstrictive properties. In the STOP trial conducted by the University Hospital Birmingham NHS Foundation Trust, it is formulated as Haelan tape—a medicated adhesive tape containing 4 micrograms of fludroxycortide per square centimeter. This specific formulation is being investigated for the treatment of hypergranulation (over-granulation) at peritoneal dialysis catheter exit sites, where it aims to reduce excessive tissue growth and inflammation. The drug functions as a glucocorticoid receptor agonist, modulating gene transcription to inhibit the release of inflammatory cytokines and stabilize lysosomal membranes. While traditionally licensed for recalcitrant dermatoses such as psoriasis and eczema, its application in hypergranulation represents a targeted use for managing wound healing complications around medical devices.

Brand names
HaelanHaelan tape
Other names
flurandrenoloneflurandrenolide
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on fludroxycortide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fludroxycortide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call